Pfaar O - Search Results

1

Novel approaches and perspectives in allergen immunotherapy.

Hoffmann HJ, Valovirta E, Pfaar O, Moingeon P, Schmid JM, Skaarup SH, Cardell LO, Simonsen K, Larché M, Durham SR, Sørensen P. Hoffmann HJ, et al. Among authors: pfaar o. Allergy. 2017 Jul;72(7):1022-1034. doi: 10.1111/all.13135. Epub 2017 Mar 20. Allergy. 2017. PMID: 28122129 Free article. Review.

2

Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements.

Pfaar O, Klimek L. Pfaar O, et al. Curr Opin Allergy Clin Immunol. 2006 Jun;6(3):161-6. doi: 10.1097/01.all.0000225153.45027.6a. Curr Opin Allergy Clin Immunol. 2006. PMID: 16670507 Review.

3

Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial.

Pfaar O, Klimek L. Pfaar O, et al. Ann Allergy Asthma Immunol. 2008 Mar;100(3):256-63. doi: 10.1016/s1081-1206(10)60451-6. Ann Allergy Asthma Immunol. 2008. PMID: 18426146 Clinical Trial.

4

Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.

Pfaar O, Klimek L, Fischer I, Sieber J, Amoroso S, Moreno Aguilar C, Shah K, Mösges R. Pfaar O, et al. Int Arch Allergy Immunol. 2009;150(1):102-8. doi: 10.1159/000210436. Epub 2009 Apr 2. Int Arch Allergy Immunol. 2009. PMID: 19339808 Clinical Trial.

5

Clinical outcome measures of specific immunotherapy.

Pfaar O, Anders C, Klimek L. Pfaar O, et al. Curr Opin Allergy Clin Immunol. 2009 Jun;9(3):208-13. doi: 10.1097/ACI.0b013e32832aef57. Curr Opin Allergy Clin Immunol. 2009. PMID: 19365259 Review.

6

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.

Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L, Pfaar O, Merk H. Ott H, et al. Among authors: pfaar o. Allergy. 2009 Sep;64(9):1394-401. doi: 10.1111/j.1398-9995.2009.02194.x. Allergy. 2009. PMID: 19764942 Clinical Trial.

7

Safety of a depigmented, polymerized vaccine for the treatment of allergic rhinoconjunctivitis and allergic asthma.

Pfaar O, Klimek L, Sager A, Bräutigam M. Pfaar O, et al. Am J Rhinol Allergy. 2010 May-Jun;24(3):220-5. doi: 10.2500/ajra.2010.24.3437. Epub 2010 Feb 17. Am J Rhinol Allergy. 2010. PMID: 20167138 Clinical Trial.

8

Cluster protocols in SCIT: enough evidence for practical use?

Pfaar O, Leitzbach S, Hörmann K, Klimek L. Pfaar O, et al. Curr Opin Allergy Clin Immunol. 2010 Jun;10(3):188-93. doi: 10.1097/ACI.0b013e328339505c. Curr Opin Allergy Clin Immunol. 2010. PMID: 20410818 Review.

9

Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis.

Pfaar O, Robinson DS, Sager A, Emuzyte R. Pfaar O, et al. Allergy. 2010 Dec;65(12):1614-21. doi: 10.1111/j.1398-9995.2010.02413.x. Allergy. 2010. PMID: 20645937 Clinical Trial.

10

Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study.

Pfaar O, Barth C, Jaschke C, Hörmann K, Klimek L. Pfaar O, et al. Int Arch Allergy Immunol. 2011;154(4):336-44. doi: 10.1159/000321826. Epub 2010 Oct 25. Int Arch Allergy Immunol. 2011. PMID: 20975285 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters